Vaporizer products – for both nicotine and THC – have dominated many headlines across the United States in recent weeks, with vaping being blamed for several deaths and severe illnesses.
While the exact cause is still unclear, the impact is being felt broadly in the cannabis industry, and investors are concerned how it may impact their portfolios.
This report takes a closer look at the vape segment of cannabis and provides a framework to assess the downside risk and upside potential of stocks with significant exposure to the sector.